KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EBT (2016 - 2026)

Medtronic (MDT) has disclosed EBT for 13 consecutive years, with $1.4 billion as the latest value for Q1 2026.

  • Quarterly EBT fell 8.83% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.6 billion through Jan 2026, up 6.55% year-over-year, with the annual reading at $5.6 billion for FY2025, 16.35% up from the prior year.
  • EBT hit $1.4 billion in Q1 2026 for Medtronic, down from $1.6 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.6 billion in Q2 2022 to a low of $855.0 million in Q2 2024.
  • Historically, EBT has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2022.
  • Biggest five-year swings in EBT: plummeted 44.87% in 2024 and later skyrocketed 47.49% in 2025.
  • Year by year, EBT stood at $1.4 billion in 2022, then decreased by 5.88% to $1.3 billion in 2023, then increased by 18.74% to $1.6 billion in 2024, then grew by 2.44% to $1.6 billion in 2025, then dropped by 12.09% to $1.4 billion in 2026.
  • Business Quant data shows EBT for MDT at $1.4 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.3 billion in Q3 2025.